To determine whether semaglutide administration is capable of promoting regression of already established atherosclerosis, WT mice were injected with PCSK9-AAV, maintained for 16 weeks on a HFHC diet, and then switched to regular chow for a 1-week washout period. Here, PCSK9 is linked to atherosclerosis.